UPPSALA, SE / ACCESSWIRE / October 15, 2024 / Senzime (STO:SEZI) (OTCQX:SNZZF) Senzime AB, a leader in perioperative patient monitoring solutions, announces the launch of its next-generation ...
UPPSALA, SE / ACCESS Newswire / August 5, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime today announced another strategic milestone in the U.S., having secured the delivery of its TetraGraph system ...
Senzime AB (publ.) announced today that the European Patent Office (EPO) has issued a new patent protecting unique capabilities of the Senzime TetraGraph system. Every year, approximately 100 million ...
UPPSALA, SE / ACCESS Newswire / December 17, 2025 / Senzime AB (publ.) (STO:SEZI)(OTCQX:SNZZF) today announced that its Next-generation TetraGraph® system has received regulatory clearance for sale in ...
UPPSALA, SE / ACCESSWIRE / January 7, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime,an industry leader in precision-based patient monitoring solutions, today announced multiple hospital contract wins ...
UPPSALA, Sweden, Oct. 28, 2024 /PRNewswire/ -- Senzime (Nasdaq Stockholm: SEZI; OTCQX: SNZZF), a global leader in perioperative patient monitoring solutions, is excited to announce the successful ...
UPPSALA, SE / ACCESSWIRE / November 8, 2023 / Senzime (STO:SEZI) Senzime, an industry leader in algorithm-based patient monitoring solutions, announces a new clinical study with the TetraGraph system ...
Adaptive IntelligenceTM : A smart suite of algorithms enabling precision-based monitoring with automated workflows throughout the perioperative journey, ensuring accurate and real-time neuromuscular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results